Bone Mineral Density in Children With Graves' Disease

Launched by ASSIUT UNIVERSITY · Apr 17, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding bone health in children who have Graves' disease, a condition that affects the thyroid and can lead to various health issues. The goal is to measure bone mineral density, which is an important factor in determining how strong a child's bones are. The study aims to gather information from children aged 2 to 17 who have been diagnosed with Graves' disease.

To participate in this trial, children must be between 2 and 17 years old and have a confirmed diagnosis of Graves' disease. Unfortunately, children younger than 2, older than 18, those who are currently being treated with specific medications for Graves' disease, or those who have other hormone-related health issues will not be eligible. If involved, participants will undergo evaluations to check their bone health, which could help improve the understanding of how Graves' disease affects growing children. This research is not yet open for recruitment, so there will be updates on when it begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age at enrollment ≥2 years to \< 18 years
• • both sexes
• • the patients should be diagnosed with graves'
• Exclusion Criteria:
• • patients less than 2 years
• • patients more than 18 years
• • Controlled GD patients on antithyroid
• • patients with other endocrine diseases